Haleen SJ - Search Results

1

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells.

Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, Wharton J. Davie N, et al. Among authors: haleen sj. Am J Respir Crit Care Med. 2002 Feb 1;165(3):398-405. doi: 10.1164/ajrccm.165.3.2104059. Am J Respir Crit Care Med. 2002. PMID: 11818328

2

Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology.

Flynn MA, Haleen SJ, Welch KM, Cheng XM, Reynolds EE. Flynn MA, et al. Among authors: haleen sj. J Cardiovasc Pharmacol. 1998 Jul;32(1):106-16. doi: 10.1097/00005344-199807000-00017. J Cardiovasc Pharmacol. 1998. PMID: 9676729

3

ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.

LaDouceur DM, Flynn MA, Keiser JA, Reynolds E, Haleen SJ. LaDouceur DM, et al. Among authors: haleen sj. Biochem Biophys Res Commun. 1993 Oct 15;196(1):209-15. doi: 10.1006/bbrc.1993.2236. Biochem Biophys Res Commun. 1993. PMID: 8216294

4

The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.

Sheedy W, Haleen S, Morice AH. Sheedy W, et al. Pulm Pharmacol Ther. 1998 Apr-Jun;11(2-3):173-6. doi: 10.1006/pupt.1998.0132. Pulm Pharmacol Ther. 1998. PMID: 9918751

5

PD 142893, SB 209670, and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ET(B)-receptor activity in the rat.

Schroeder RL, Keiser JA, Cheng XM, Haleen SJ. Schroeder RL, et al. Among authors: haleen sj. J Cardiovasc Pharmacol. 1998 Dec;32(6):935-43. doi: 10.1097/00005344-199812000-00010. J Cardiovasc Pharmacol. 1998. PMID: 9869499

6

Butenolide endothelin antagonists with improved aqueous solubility.

Patt WC, Cheng XM, Repine JT, Lee C, Reisdorph BR, Massa MA, Doherty AM, Welch KM, Bryant JW, Flynn MA, Walker DM, Schroeder RL, Haleen SJ, Keiser JA. Patt WC, et al. Among authors: haleen sj. J Med Chem. 1999 Jun 17;42(12):2162-8. doi: 10.1021/jm980504w. J Med Chem. 1999. PMID: 10377221

7

The endothelin-A-receptor antagonist PD 180988 (CI-1034) selectively reverses the pulmonary vasoconstrictor response to hypoxia in the lamb.

Coe Y, Haleen SJ, Welch KM, Coceani F. Coe Y, et al. Among authors: haleen sj. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S331-3. doi: 10.1097/00005344-200036051-00096. J Cardiovasc Pharmacol. 2000. PMID: 11078412

8

Cardiopulmonary indications for endothelin receptor antagonists: review of recent efficacy trials.

Haleen SJ, Cheng XM. Haleen SJ, et al. Expert Opin Investig Drugs. 1997 May;6(5):475-87. doi: 10.1517/13543784.6.5.475. Expert Opin Investig Drugs. 1997. PMID: 15989614

9

The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb.

Coe Y, Haleen SJ, Welch KM, Liu YA, Coceani F. Coe Y, et al. Among authors: haleen sj. J Pharmacol Exp Ther. 2002 Aug;302(2):672-80. doi: 10.1124/jpet.302.2.672. J Pharmacol Exp Ther. 2002. PMID: 12130731

10

Why big endothelin-1 lacks a vasodilator response.

Haleen SJ, Davis LS, LaDouceur DM, Keiser JA. Haleen SJ, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S271-3. doi: 10.1097/00005344-199322008-00071. J Cardiovasc Pharmacol. 1993. PMID: 7509963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters